These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2651332)

  • 1. A controlled multicentre therapeutic trial to determine the efficacy of a novel antacid (AI-Mg-hydroxy-carbonate) in duodenal ulcer.
    Nagy L; Nagy G; Rácz I; Simon L; Solt I; Patty I; Tárnok F; Mózsik G; Jávor T
    Int J Clin Pharmacol Res; 1989; 9(1):85-92. PubMed ID: 2651332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of duodenal ulcers by antacid (Al-Mg-hydroxy-carbonate). A controlled, randomized, prospective, multicentre clinical trial.
    Nagy L; Nagy G; Rácz I; Simon L; Solt I; Patty I; Tárnok F; Mózsik G; Jávor T
    Acta Physiol Hung; 1989; 73(2-3):331-9. PubMed ID: 2688360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a novel Hungarian antacid containing Al and Mg (Tisacid) on mucosal prostaglandin generation and oxygen free radicals in normal rats.
    Nagy L; Mózsik G; Vincze A; Süto G ; Hunyady B; Rinfel J; Past T; Jávor T
    Drugs Exp Clin Res; 1990; 16(4):197-203. PubMed ID: 2076656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human tolerability and pharmacodynamic study of Tisacid tablet in duodenal ulcer patients. A prospective, randomized, self-controlled clinicopharmacological study.
    Nagy L; Tárnok F; Past T; Mózsik G; Deák G; Tapsonyi Z; Fendler K; Jávor T
    Acta Med Hung; 1988; 45(2):231-47. PubMed ID: 3073355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of duodenal ulcer with antacid and sulpiride. A double-blind controlled study.
    Lam SK; Lam KC; Lai CL; Yeung CK; Yam LY; Wong WS
    Gastroenterology; 1979 Feb; 76(2):315-22. PubMed ID: 365665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antacid therapy of duodenal ulcer. Effects of smaller doses.
    Berstad A
    Scand J Gastroenterol Suppl; 1982; 75():97-9. PubMed ID: 6128786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Testing the acid-binding capacity of Tisacid suspension and tablets by intragastric pH determination in patients with hyperacidity].
    Hunyady B; Ciráki A; Vińcze A; Garamszegi M; Nagy L; Jávor T
    Orv Hetil; 1994 Jun; 135(25):1353-6. PubMed ID: 8008366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lattice structure antacids and antacid mixtures].
    Miederer SE; Schmidt C
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():130-5. PubMed ID: 3660893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healing of duodenal ulcer with an antacid regimen.
    Peterson WL; Sturdevant RA; Frankl HD; Richardson CT; Isenberg JI; Elashoff JD; Sones JQ; Gross RA; McCallum RW; Fordtran JS
    N Engl J Med; 1977 Aug; 297(7):341-5. PubMed ID: 876324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled clinical assessment of the efficacy and tolerance of triletide versus antacids in patients with gastric and duodenal ulcers.
    Hoetzinger H
    Pharmatherapeutica; 1985; 4(3 Spec No):155-60. PubMed ID: 3903784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent ulcer after successful treatment with cimetidine or antacid.
    Ippoliti A; Elashoff J; Valenzuela J; Cano R; Frankl H; Samloff M; Koretz R
    Gastroenterology; 1983 Oct; 85(4):875-80. PubMed ID: 6350097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of smoking on healing rate of duodenal ulcer in response to cimetidine or high-dose antacid.
    Korman MG; Shaw RG; Hansky J; Schmidt GT; Stern AI
    Gastroenterology; 1981 Jun; 80(6):1451-3. PubMed ID: 7227770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duodenal ulcer healing with four antacid tablets daily.
    Weberg R; Berstad A; Lange O; Schultz T; Aubert E
    Scand J Gastroenterol; 1985 Nov; 20(9):1041-5. PubMed ID: 3911365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of gastric pyrosis with almagate in patients with and without endoscopically demonstrable duodenal ulcer. A multicentre clinical trial.
    Suau A; Dominguez Martin A; Ferrando Cucarella J; Juncosa Iglesias L; Muñoz Benitez J; Nieto Calvet M; Pérez Gieb J; Pérez Mota A; Pineda Garcia A; Rodriguez Sanchez E
    Arzneimittelforschung; 1984; 34(10A):1380-3. PubMed ID: 6548926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acute duodenal ulcer--a Swedish multicenter study.
    Glise H; Carling L; Hallerbäck B; Kagevi I; Solhaug JH; Svedberg LE; Wählby L
    Scand J Gastroenterol Suppl; 1987; 127():61-6. PubMed ID: 3303293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a new antacid on basal and meal-stimulated gastric secretion.
    Sun DC; Rider JA
    Am J Gastroenterol; 1978 Mar; 69(3 Pt 1):283-8. PubMed ID: 27093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of a new antacid in duodenal ulcer].
    Panijel M
    Med Welt; 1982 Mar; 33(11):415-7. PubMed ID: 7045563
    [No Abstract]   [Full Text] [Related]  

  • 18. Antacids and anticholinergics in the treatment of duodenal ulcer.
    Walan A
    Clin Gastroenterol; 1984 May; 13(2):473-99. PubMed ID: 6086186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse rates of duodenal ulcer healed with concentrated antacid or cimetidine.
    Hentschel E; Schuetze K; Dufek W
    Hepatogastroenterology; 1984 Dec; 31(6):266-8. PubMed ID: 6519637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of a new antacid, synthetic hydrotalcite, in duodenal ulcer: clinical endoscopic study compared to cimetidine].
    Piai G; Cimino L; D'Argenio G; Mazzacca G
    Clin Ter; 1980 Nov; 95(3):269-77. PubMed ID: 7214842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.